Office of
Public Affairs
General Information: 202-326-2180
>>
Releases by Month and Year<<
October 20, 2004
- Statement of the Federal Trade Commission Regarding the Decision to Close Its Investigation into the Conduct of Akzo Nobel, NV and Its Organon Subsidiary
- For Your Information:
Announced Actions for October 20, 2004
The Commission has authorized the staff to file an amended complaint in the currently pending matter concerning Chase Financial Funding, Inc., et al. ; The Commission has authorized the staff to file an amended complaint in the currently pending matter concerning Pharmacycards.com, et al.; The Commission has received an application from AspenTechnology, Inc. (AspenTech), requesting FTC approval to divest its Engineering Software Assets, as that term is defined in the Commission’s proposed order announced on July 15, 2004, to Honeywell International, Inc.
October 19, 2004
October 15, 2004
October 13, 2004
October 12, 2004
October 8, 2004
October 7, 2004
October 6, 2004
October 5, 2004
- FTC Targets Products Claiming to Affect the Stress Hormone Cortisol
Agency Alleges That Marketers of CortiSlim and CortiStress Made False or Unsubstantiated Claims
- For Your Information:
Announced Actions for October 5, 2004
Following a public comment period, the Commission has approved a final consent order in the matter concerning the Virginia Board of Funeral Directors and Embalmers.; Following a public comment period, the Commission has approved a final consent order in the matter concerning Piedmont Health Alliance, Inc., et al.
October 1, 2004
Last Updated:
Thursday, October 21, 2004
|